# Aquestive Therapeutics, Inc.: Form 8-K, filed Apr 1, 2025

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2025-04-01
- Accepted by EDGAR: Apr 1, 2025, 12:26 ET
- Period: 2025-04-01
- Accession: 0001628280-25-015759
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000162828025015759/aqst-20250401.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000162828025015759/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000162828025015759/aqst-20250401.htm

Filed Apr 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-015759. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.